Life Healthcare FY HEPS down 16.9%
Peter Wharton-Hood, CEO, Life Healthcare joins CNBC Africa’s Godfrey Mutizwa to unpack the numbers.
Thu, 16 Nov 2023 10:54:50 GMT
Disclaimer: The following content is generated automatically by a GPT AI and may not be accurate. To verify the details, please watch the video
AI Generated Summary
- Life Healthcare reports a loss in the current year due to the disposal of Alliance Medical Group but projects a profit in the upcoming year
- Operational performance in the South African business sector shows revenue growth and increased patient volumes despite COVID-19 challenges
- Recruitment of doctors and support for universal healthcare highlight Life Healthcare's commitment to healthcare provision and workforce development
Life Healthcare, a leading healthcare provider, recently announced its financial results for the year, revealing a complex picture of gains and losses. In a CNBC Africa interview with CEO Peter Wharton-Hood, key insights were shared regarding the company's performance, the impact of COVID-19, and concerns about the National Health Insurance (NHI) bill.
Wharton-Hood discussed the intricacies of the company's financial results, highlighting the disposal of the Alliance Medical Group as a significant factor affecting the reported numbers. While the current year saw a loss of about 900 million Rand due to this transaction, the upcoming year is projected to bring a profit of 2.9 billion Rand, resulting in a net profit of 2 billion Rand from the disposal of AMG.
Despite the challenges posed by the disposal, the company's operating performance showed positive signs. In the South African business sector, revenue was up by 10%, normalized EBITDA increased by over 6.6%, and there was a notable growth in underlying paid patient days. The strong performance from Alliance Medical also contributed to the overall positive outlook for the company.
Regarding the impact of COVID-19 on healthcare operations, Wharton-Hood acknowledged a significant decrease in patient volumes across the complexes, attributing it to the 'new normal' post-pandemic. However, with strategic network deals in place with medical aid insurers, the company aims to grow patient volumes by approximately 3% in 2024, nearing pre-COVID occupancy levels.
One noteworthy highlight from the interview was the company's focus on recruiting more doctors, countering the common narrative of doctors emigrating from South Africa. Wharton-Hood emphasized that while some doctors did leave, the net recruitment of specialists was positive, indicating the company's commitment to building a strong clinical workforce.
The conversation also delved into the implications of the NHI bill on private healthcare providers like Life Healthcare. Wharton-Hood expressed support for universal healthcare but emphasized the need for a collaborative approach between the government and the private sector. He underscored the importance of addressing fundamental challenges like the shortage of healthcare professionals and infrastructure upgrades to ensure the successful implementation of NHI.
In conclusion, Wharton-Hood's insights shed light on not just the financial performance of Life Healthcare but also the broader healthcare landscape in South Africa. As the company navigates through financial complexities, operational growth, and regulatory challenges, the focus remains on delivering quality healthcare services while addressing the industry's evolving needs.